Unknown

Dataset Information

0

The evolving treatment paradigm for BRAF V600 mutant colorectal cancer.

ABSTRACT:

SUBMITTER: Kratz JD 

PROVIDER: S-EPMC6976492 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The evolving treatment paradigm for BRAF V600 mutant colorectal cancer.

Kratz Jeremy D JD   Deming Dustin A DA  

Annals of translational medicine 20191201 Suppl 8

Similar Datasets

Unknown Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.
| S-EPMC4669588 | biostudies-literature
Unknown Emerging treatment options for BRAF-mutant colorectal cancer.
| S-EPMC5889076 | biostudies-literature
Unknown Contemporary treatment approaches for metastatic colorectal cancer driven by <i>BRAF</i> V600 mutations.
| S-EPMC7579731 | biostudies-literature
Unknown Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant Tumors.
| S-EPMC9355618 | biostudies-literature
Unknown Dosing matters: DESTINY-CRC02 and the evolving treatment paradigm for HER2 positive colorectal cancer.
| S-EPMC12314705 | biostudies-literature
Unknown Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.
| S-EPMC3724515 | biostudies-literature
Unknown Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer.
| S-EPMC10225206 | biostudies-literature
Unknown Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i> <sup>V600</sup>-Mutant Non-Melanoma Cancers.
| S-EPMC7196502 | biostudies-literature
Unknown The evolving treatment paradigm of lung cancer in China.
| S-EPMC9069462 | biostudies-literature
Unknown BRAF Inhibition in <i>BRAF</i><sup>V600</sup>-Mutant Gliomas: Results From the VE-BASKET Study.
| S-EPMC6286161 | biostudies-literature